NCT00297349View on ClinicalTrials.gov

A Study of the Safety of Topiramate Given in Combination With Other Medications in Adults and Children With Seizures

CompletedOBSERVATIONAL
Enrollment

153

Participants

Timeline

Start Date

November 30, 2003

Study Completion Date

June 30, 2005

Conditions
SeizuresEpilepsy
Interventions
DRUG

Topiramate

Individualization of the treatment should begin from 25 mg for 1 week.

All Listed Sponsors
lead

Janssen Cilag Pharmaceutica S.A.C.I., Greece

INDUSTRY

NCT00297349 - A Study of the Safety of Topiramate Given in Combination With Other Medications in Adults and Children With Seizures | Biotech Hunter | Biotech Hunter